Rat KidneyMAP® v 1.0
The Myriad RBM Rat KidneyMAP detects early signs of renal damage which is a common problem in drug development programs. Developed in conjunction with the Predictive Safety Testing Consortium, it provides a sensitive and quantitative method to detect drug-induced kidney damage early before irreparable damage has occurred. This will accelerate decisions on pre-clinical testing protocols.
|1. Albumin Rat||2. Beta-2-Microglobulin|
|3. Calbindin||4. Clusterin|
|5. Cystatin-C||6. Epidermal Growth Factor|
|7. Glutathione S-Transferase Mu||8. Glutathione S-Transferase alpha|
|9. Kidney Injury Molecule-1||10. Neutrophil Gelatinase-Associated Lipocalin|
|11. Osteopontin||12. Tissue Inhibitor of Metalloproteinases 1|
|13. Vascular Endothelial Growth Factor A|
Intended for Research Use Only.